Literature DB >> 6123609

Characteristics of [3H]E-643-binding to alpha adrenoceptors.

F Hata, E Kondo, S Kondo, K Kagawa, H Ishida.   

Abstract

Radiolabeled E-643, a newly developed antihypertensive compound, bound specifically to a preparation obtained from rat brain with a maximum of 85 f moles of binding sites per mg protein and a dissociation constant of 0.59 nM. Prazosin markedly inhibited the binding. While yohimbine and clonidine were only weak inhibitors. Other characteristics of the binding of [3H]E-643 to the brain and its specific binding to preparations of peripheral rat organs were also studied. The present findings suggest that [3H]E-643 is useful for labeling alpha 1-adrenoceptors.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6123609     DOI: 10.1254/jjp.32.181

Source DB:  PubMed          Journal:  Jpn J Pharmacol        ISSN: 0021-5198


  4 in total

1.  The aortic alpha 1-adrenergic receptor in familial amyloidotic polyneuropathy.

Authors:  T Azuma; Y Watanabe; T Suzuki; S Sakoda; S Higa; R Mizuno; S Tsujino; S Kishimoto; H Yoshida
Journal:  J Neural Transm       Date:  1988       Impact factor: 3.575

2.  Pharmacological properties of alpha 1-adrenoceptor-mediated vasoconstrictions in dog and monkey lingual arteries: evidence for subtypes of alpha 1-adrenoceptors.

Authors:  R Skrbic; S Chiba
Journal:  Heart Vessels       Date:  1992       Impact factor: 2.037

3.  Acute effect of an alpha 1-adrenoceptor antagonist on urinary sodium excretion, plasma atrial natriuretic peptide, arginine vasopressin, and the renin-aldosterone system in healthy subjects.

Authors:  T Tomiyama; T Baba; S Murabayashi; T Ishizaki
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

4.  Bunazosin in patients with impaired hepatic or renal function.

Authors:  A Halabi; A Nokhodian; W Kirch
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1993 Jul-Sep       Impact factor: 2.441

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.